Suppr超能文献

原创研究论文。喷雾干燥法制备的含盐酸西替利嗪和甲基丙烯酸酯类共聚物微粒的表征及掩味评价

Original research paper. Characterization and taste masking evaluation of microparticles with cetirizine dihydrochloride and methacrylate-based copolymer obtained by spray drying.

作者信息

Amelian Aleksandra, Szekalska Marta, Ciosek Patrycja, Basa Anna, Winnicka Katarzyna

出版信息

Acta Pharm. 2017 Mar 1;67(1):113-124. doi: 10.1515/acph-2017-0002.

Abstract

Taste of a pharmaceutical formulation is an important parameter for the effectiveness of pharmacotherapy. Cetirizine dihydrochloride (CET) is a second-generation antihistamine that is commonly administered in allergy treatment. CET is characterized by extremely bitter taste and it is a great challenge to successfully mask its taste; therefore the goal of this work was to formulate and characterize the microparticles obtained by the spray drying method with CET and poly(butyl methacrylate-co-(2-dimethylaminoethyl) methacrylate-co-methyl methacrylate 1:2:1 copolymer (Eudragit E PO) as a barrier coating. Assessment of taste masking by the electronic tongue has revealed that designed formulations created an effective taste masking barrier. Taste masking effect was also confirmed by the in vivo model and the in vitro release profile of CET. Obtained data have shown that microparticles with a drug/polymer ratio (0.5:1) are promising CET carriers with efficient taste masking potential and might be further used in designing orodispersible dosage forms with CET.

摘要

药物制剂的口感是药物治疗有效性的一个重要参数。盐酸西替利嗪(CET)是一种常用于过敏治疗的第二代抗组胺药。CET具有极苦的味道,成功掩盖其味道是一项巨大挑战;因此,本研究的目的是制备并表征通过喷雾干燥法获得的微粒,该微粒以CET和聚(甲基丙烯酸丁酯-co-(2-二甲基氨基乙基)甲基丙烯酸酯-co-甲基丙烯酸甲酯1:2:1共聚物)(Eudragit E PO)作为包衣。通过电子舌对掩味效果的评估表明,所设计的制剂形成了有效的掩味屏障。体内模型和CET的体外释放曲线也证实了掩味效果。所得数据表明,药物/聚合物比例为(0.5:1)的微粒是有前景的CET载体,具有高效的掩味潜力,可进一步用于设计含CET的口腔崩解剂型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验